Photobiomodulation with Near Infrared Light Helmet in a Pilot, Placebo Controlled Clinical Trial in Dementia Patients Testing Memory and Cognition.

@article{Berman2017PhotobiomodulationWN,
  title={Photobiomodulation with Near Infrared Light Helmet in a Pilot, Placebo Controlled Clinical Trial in Dementia Patients Testing Memory and Cognition.},
  author={Marvin H. Berman and James P. Halper and Trent W. Nichols and H Jarrett and Alan Lundy and Jason H. Huang},
  journal={Journal of neurology and neuroscience},
  year={2017},
  volume={8 1}
}
Alzheimer's disease (AD) is a common, chronic expensive debilitating neurodegenerative disease with no current treatments to prevent the physical deterioration of the brain and the consequent cognitive deficits. The current pathophysiology of Alzheimer's disease is the accumulation of neurofibrillary tangles (NFTs) of hyperphosphorylated tau protein and amyloid-beta (Aβ) plaques. Antibody therapy of Tau and Amyloid beta, vaccines and other methods to decrease Tau and or Amyloid have not been… Expand

Paper Mentions

Interventional Clinical Trial
Photobiomodulation (PBM) describes the use of near-infrared light (which is not visible to the eye) to heal and protect tissue that has either been injured, is degenerating, or else is… Expand
ConditionsAlzheimer Disease
InterventionDevice, Other
Interventional Clinical Trial
This study will employ a double-blind, placebo-controlled approach to assess the effect of 1072nm infrared (IR) phototherapy on the behavioral and cognitive symptoms associated with… Expand
ConditionsDementia
InterventionDevice
Photobiomodulation for Alzheimer's Disease: Has the Light Dawned?
TLDR
The present review discusses the mechanisms of action of tPBM in the brain, and summarizes studies that have used tP BM to treat animal models of AD. Expand
The Growing Evidence for Photobiomodulation as a Promising Treatment for Alzheimer ’ s Disease
Despite the current belief that there is no effective treatment for Alzheimer’s Disease (AD), one emerging modality may change this belief: Photobiomodulation (PBM). It has credible mechanisms andExpand
The Growing Evidence for Photobiomodulation as a Promising Treatment for Alzheimer ’ s Disease
Despite the current belief that there is no effective treatment for Alzheimer’s Disease (AD), one emerging modality may change this belief: Photobiomodulation (PBM). It has credible mechanisms andExpand
#neverforget - Photobiomodulation Against Alzheimer's Disease: A Systematic Review
TLDR
A comprehensive summary on the available research on photobiomodulation against Alzheimer's disease shows that the mechanistic action has been largely understood on a cellular level, safe and effective doses have been found in animal models, and first human case studies provide reason to enter large scale clinical trials. Expand
Treatment of Neurodegeneration: Integrating Photobiomodulation and Neurofeedback in Alzheimer's Dementia and Parkinson's: A Review.
TLDR
Next-generation trials with the Cognitolite for Parkinson's disease subjects will incorporate the insights regarding significant bilateral occipital hypocoherence deficits gained from the quantitative EEG analyses. Expand
Photobiomodulation for Alzheimer’s Disease: Translating Basic Research to Clinical Application
TLDR
This review covers the literature on photobiomodulation therapy as a novel approach to prevent and treat Alzheimer’s disease, aiming to bridge the gap by gathering together the terms and technical specifications into a single concise suggestion for a treatment protocol. Expand
Improvements in the clinical signs of Parkinson's disease using photobiomodulation: a prospective proof of concept study
TLDR
Photobiomodulation was shown to be a safe and potentially effective treatment for a range of clinical signs and symptoms of PD and indicates that a large RCT is warranted. Expand
Improvements in clinical signs of Parkinson’s disease using photobiomodulation: a prospective proof-of-concept study
TLDR
Photobiomodulation was shown to be a safe and potentially effective treatment for a range of clinical signs and symptoms of PD and indicates that a large RCT is warranted. Expand
Microglia modulation with 1070-nm light attenuates Aβ burden and cognitive impairment in Alzheimer’s disease mouse model
  • Lechan Tao, Qi Liu, +9 authors Xunbin Wei
  • Medicine
  • Light, science & applications
  • 2021
TLDR
It is demonstrated that cognitive and memory impairment in an AD mouse model can be ameliorated by 1070-nm light via reducing cerebral β-amyloid burden, the hallmark of AD. Expand
Therapeutic potential of intranasal photobiomodulation therapy for neurological and neuropsychiatric disorders: a narrative review
TLDR
Evidence shows that nostril-based PBMT improves blood rheology and cerebral blood flow, so that, without needing to puncture blood vessels, i-PBMT may have equivalent results to a peripheral intravenous laser irradiation procedure. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 28 REFERENCES
Photobiomodulation with near infrared light mitigates Alzheimer’s disease-related pathology in cerebral cortex – evidence from two transgenic mouse models
TLDR
The results suggest that NIr may have potential as an effective, minimally-invasive intervention for mitigating, and even reversing, progressive cerebral degenerations. Expand
A three-dimensional human neural cell culture model of Alzheimer’s disease
TLDR
This work reports that FAD mutations in β-amyloid precursor protein and presenilin 1 are able to induce robust extracellular deposition of amyloid-β, including amyloids-β plaques, in a human neural stem-cell-derived three-dimensional (3D) culture system, and successfully recapitulated Alzheimer’s disease pathology in a single 3D human neural cell culture system. Expand
Potential for transcranial laser or LED therapy to treat stroke, traumatic brain injury, and neurodegenerative disease.
TLDR
The main mechanisms of action of transcranial light therapy (TLT) in ameliorating brain damage (prevention of neuronal death and increased neurogenesis) have motivated studies in both animals and humans for diverse brain disorders and diseases. Expand
Hyperphosphorylation of Tau Protein in DownâÂÂs Dementia andAlzheimerâÂÂs Disease: Methylation and Implications in Prevention andTherapy
The changes of insulin signaling, calcium signaling, mitochondrial decline and oxidative stress have been implicated in the hyperphosphorylation of tau protein found in Downs syndrome dementia. SuchExpand
Role of Low‐Level Laser Therapy in Neurorehabilitation
TLDR
This review will cover the mechanisms of low‐level laser therapy that operate both on a cellular and a tissue level and animal studies and human clinical trials of LLLT for indications with relevance to neurology, such as stroke, traumatic brain injury, degenerative brain disease, spinal cord injury, and peripheral nerve regeneration. Expand
Alzheimer's disease - a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria
  • J. Miklossy
  • Medicine, Biology
  • Journal of Neuroinflammation
  • 2011
TLDR
A probable causal relationship between neurospirochetosis and AD is shown and adequate antibiotic and anti-inflammatory therapies are available, as in syphilis, one might prevent and eradicate dementia. Expand
Significant improvements in cognitive performance post-transcranial, red/near-infrared light-emitting diode treatments in chronic, mild traumatic brain injury: open-protocol study.
This pilot, open-protocol study examined whether scalp application of red and near-infrared (NIR) light-emitting diodes (LED) could improve cognition in patients with chronic, mild traumatic brainExpand
The Alzheimer's disease mitochondrial cascade hypothesis.
TLDR
It is increasingly accepted by the AD research community that mitochondria play an important role in the late-onset forms of the disease, and the mitochondrial cascade hypothesis identifies alternative therapeutic targets. Expand
Alzheimer’s disease drug-development pipeline: few candidates, frequent failures
TLDR
It is demonstrated that relatively few clinical trials are undertaken for AD therapeutics, considering the magnitude of the problem, and the success rate for advancing from one phase to another is low and the number of compounds progressing to regulatory review is among the lowest found in any therapeutic area. Expand
Alzheimer’s Disease: A Novel Hypothesis Integrating Spirochetes, Biofilm, and the Immune System
In the light of recent studies showing the presence of spirochetes in the brains of Alzheimer’s disease (AD) patients, we have studied (post mortem) the hippocampus region in the brains of similarlyExpand
...
1
2
3
...